These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma. Wang Q, Chen Q, Zhang X, Lu XL, Du Q, Zhu T, Zhang GY, Wang DS, Fan QM. World J Gastroenterol; 2019 Sep 28; 25(36):5515-5529. PubMed ID: 31576097 [Abstract] [Full Text] [Related]
5. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA. Wu J, Xiang Z, Bai L, He L, Tan L, Hu M, Ren Y. Cancer Biomark; 2018 Sep 28; 23(2):235-242. PubMed ID: 30103302 [Abstract] [Full Text] [Related]
8. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis. Ng YY, Lin CC, Wu SC, Hwang SJ, Ho CH, Yang WC, Lee SD. Clin Nephrol; 2002 Apr 28; 57(4):289-95. PubMed ID: 12005245 [Abstract] [Full Text] [Related]
11. Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection. Gentile I, Buonomo AR, Scotto R, Zappulo E, Carriero C, Piccirillo M, Izzo F, Rizzo M, Cerasuolo D, Borgia G, Cavalcanti E. In Vivo; 2017 Apr 28; 31(4):695-700. PubMed ID: 28652441 [Abstract] [Full Text] [Related]
12. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K. World J Gastroenterol; 2015 Apr 28; 21(16):4933-45. PubMed ID: 25945007 [Abstract] [Full Text] [Related]
16. Gamma glutamyltranspeptidase activity and viral hepatitis in dialysis population. Fabrizi F, De Vecchi AF, Qureshi AR, Aucella F, Lunghi G, Bruchfeld A, Bisegna S, Mangano S, Limido A, Vigilante D, Forcella M, Delli Carri P, Martin P. Int J Artif Organs; 2007 Jan 28; 30(1):6-15. PubMed ID: 17295188 [Abstract] [Full Text] [Related]
19. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. Caviglia GP, Abate ML, Gaia S, Petrini E, Bosco C, Olivero A, Rosso C, Ciancio A, Pellicano R, Saracco GM, Rizzetto M, Smedile A. Panminerva Med; 2017 Dec 28; 59(4):283-289. PubMed ID: 28650134 [Abstract] [Full Text] [Related]
20. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. J Clin Gastroenterol; 2009 Dec 28; 43(5):482-8. PubMed ID: 19197197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]